FGPHF (FGPHF) Stock Price & Analysis
FGPHF (FGPHF) rose 2.56% to USD 0.04 as of September 8, 2026 at 10:55 UTC, according to Nexqual real-time market data.
FGPHF last closed at USD 0.04; the session ranged USD 0.04–0.04 on volume of 4,100 shares. Market capitalization is $35.39M, with a 52-week range of USD 0.04–0.13 (OQB). Source: Nexqual, September 8, 2026 at 10:55 UTC.
Key Statistics (as of September 8, 2026 at 10:55 UTC)
| Price | USD 0.04 |
|---|---|
| Change | ▲ 2.56% (up) |
| Previous Close | USD 0.04 |
| Open | USD 0.04 |
| Day Range | USD 0.04 – 0.04 |
| 52-Week Range | USD 0.04 – 0.13 |
| Volume | 4,100 shares |
| Market Cap | $35.39M |
| Exchange | OQB |
Technical Analysis (FGPHF)
Nexqual's technical model rates FGPHF "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 10:55 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 40.77 (neutral) |
| vs SMA50 | Below (USD 0.05) |
| MACD | -0 (negative) |
Analyst Ratings (FGPHF)
Wall Street analysts rate FGPHF "None", per Nexqual as of September 8, 2026 at 10:55 UTC.
| Consensus Rating | None |
|---|
Earnings (FGPHF)
Source: Nexqual, September 8, 2026 at 10:55 UTC.
Financials & Fundamentals (FGPHF)
| Total Revenue | $537,594 |
|---|---|
| Gross Margin | +32.56% |
| Operating Margin | -942.00% |
| Profit Margin | +0.00% |
| ROE | -93.30% |
| Debt / Equity | 4.8 |
| Current Ratio | 4.07 |
| Total Cash | $2.87M |
| Total Debt | $339,361 |
| Free Cash Flow | $-2.91M |
Source: Nexqual, September 8, 2026 at 10:55 UTC.
Financial Health Score (FGPHF)
Nexqual rates FGPHF's overall financial health "Weak" across five dimensions, as of September 8, 2026 at 10:55 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $3M cash, no debt |
| Cash Flow | Weak — FCF negative: -$3M, burning cash |
| Efficiency | Critical — ROE -93%, ROA -28.9% |
Ownership (FGPHF)
| Insider Ownership | +19.54% |
|---|---|
| Institutional Ownership | +0.01% |
| Shares Outstanding | 884.76M |
| Float | 750.61M |
Source: Nexqual, September 8, 2026 at 10:55 UTC.
Leadership (FGPHF)
FGPHF is led by Michael Bell, MD, CEO & Director, per Nexqual as of September 8, 2026 at 10:55 UTC.
| MD, CEO & Director | Michael Bell |
|---|---|
| Senior Scientific Advisor & Non Executive Director | Andrew Goodwin |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HDGHF | HAYDALE PLC | USD 0 | ▲ 0% |
| NNXPF | Nanoxplore Inc. | USD 1.14 | ▲ 0.8% |
| VRSRF | Versarien Plc | USD 0 | ▲ 0% |
| ZTEKF | Zentek Ltd. | USD 0.56 | ▲ 16.67% |
| GMGMF | Graphene Manufacturing Group Lt | USD 1.82 | ▲ 9.18% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:55 UTC. This page is informational and not investment advice.